Merus N.V. (MRUS) Merus N.V. is a clinical-stage oncology company focused on developing innovative bispecific antibody therapies for cancer treatment. Its proprietary Biclonics® platform is designed to address unmet medical needs in solid tumors and blood cancers. Key drivers include pipeline progress, clinical trial data, and partnerships. Chart Duos Technologies Group, Inc. (DUOT) Duos Technologies […]
Read MoreKratos Defense & Security Solutions, Inc. (KTOS) Kratos Defense & Security Solutions, Inc. develops and manufactures advanced defense and security technologies for the U.S. government and its allies. The company specializes in unmanned systems, satellite communications, missile defense, and directed energy. Its core strength lies in affordable, rapidly deployable systems that fill strategic gaps for […]
Read MoreSoleno Therapeutics, Inc. (SLNO) Soleno Therapeutics, Inc. is a biopharmaceutical company focused on rare diseases, with its lead candidate targeting Prader-Willi syndrome (PWS), a complex genetic disorder. The company’s primary product, diazoxide choline controlled-release (DCCR), is an oral therapy designed to address the unmet needs in PWS by reducing hyperphagia and improving metabolic outcomes. It […]
Read MoreExagen Inc. (XGN) Exagen Inc. is a healthcare company focused on delivering advanced diagnostic tests for autoimmune diseases. Its flagship product, AVISE CTD, helps physicians diagnose systemic lupus erythematosus and other connective tissue diseases more accurately. The company integrates lab services, proprietary testing, and data analytics to improve diagnosis and disease monitoring, ultimately enhancing patient […]
Read More